Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

The second episode of our ‘Enabling Successful Sites’ series features a discussion between Karen McIntyre (Vice President, Global Site Alliances), Xoli Belgrave (Sr. Director, Head of Clinical Trial Diversity and Inclusion), Jamie Langley (Executive Director, Parexel Academy) and Dr. Lovie Negrin, CEO and Founder of Randomize now on how we can empower and leverage sites with the tools and training they need to more successfully recruit diverse patient populations for their studies. They talk about the impact of not including diverse patient populations in studies is discussed, the need for sponsors and CROs to share their diversity, equity, and inclusion strategies with investigator sites, and soft skills site staff need to have for necessary conversations.

 

 

Episode 1: Site feasibility and study start-up challenges

Return to Insights Center

Related Insights

Podcast

De-risking Drug Development | Episode 1: How to drive value in pre-clinical development

May 28, 2024

Podcast

Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials

Jun 28, 2024

Playbook

Insights from the 2022 R&D Innovation Survey

Feb 17, 2023

Blog

Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024

Article

Key strategies to mitigate the risks of asthma drug development

Jan 24, 2025

Blog

Best practices and lessons learned in a challenging IBD study

Jul 19, 2023

Article

Making rare disease drug development personal

Jan 8, 2021

Blog

How sponsors can make it easier for rare disease patients and families to participate in trials

Feb 13, 2024

Webinar

Accelerating vaccine development through operational excellence

May 16, 2024

Blog

ASGCT 2024: AAV Gene Therapy is Now, but Gene Editing is the Future

May 15, 2024

Report

New Medicines, Novel Insights: Advancing Precision Oncology

May 14, 2024

Blog

Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial

Nov 19, 2021

Related Insights

Podcast

De-risking Drug Development | Episode 1: How to drive value in pre-clinical development

May 28, 2024

Podcast

Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials

Jun 28, 2024

Playbook

Insights from the 2022 R&D Innovation Survey

Feb 17, 2023

Blog

Making cell and gene therapy more accessible in the treatment of solid tumors

Jun 4, 2024

Article

Key strategies to mitigate the risks of asthma drug development

Jan 24, 2025

Blog

Best practices and lessons learned in a challenging IBD study

Jul 19, 2023

Show more